Business
DigiPath Labs Colorado LLC Awarded a Conditional State License to Open a Testing Lab in Colorado
DigiPath Labs Colorado LLC Awarded a Conditional State License to Open a Testing Lab in Colorado.
About this update from Hypha Labs, Inc.
[{"type":"text","content":"\n\n\n\nDigiPath Labs Colorado LLC Awarded a Conditional State License to Open a Testing Lab in Colorado\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nDigiPath Labs Colorado LLC Awarded a Conditional State License to Open a Testing Lab in Colorado\nPR Newswire\nLAS VEGAS, Jan. 20, 2016\n\n\n\nLAS VEGAS, Jan. 20, 2016 /PRNewswire/ -- DigiPath, Inc. (OTCQB: DIGP) announced today that its affiliate, DigiPath Labs Colorado LLC, has been granted a conditional state license to operate a cannabis testing facility in Denver, Colorado. In accordance with Colorado licensing requirements, Dr. Cindy Orser, a Colorado resident, is the sole owner of DigiPath Labs Colorado. Dr. Orser serves as the Chief Science Officer of DigiPath Labs Inc., and is a cannabis-testing expert who frequently speaks on the importance of quality assurance, the dangers of pesticide contamination, and the need for standard testing protocols. DigiPath Labs Colorado intends to license the standard operating procedures developed and validated for cannabis testing by DigiPath Labs, Inc. in Las Vegas, Nevada.\n\n\n\"Obtaining a conditional license is the first step in the licensing requirements required for the opening of a cannabis testing lab in the State of Colorado.  DigiPath Labs Colorado plans to bring reliable, replicable quality assurance and potency testing to the Colorado cannabis market, which will benefit Colorado's cannabis industry—from the producer to the dispensary owner to the state — from a business liability and consumer and patient safety standpoint,\" says Dr. Orser.\n\n\"Contaminants in cannabis can aggravate or even cause patient health problems, such as liver disease,\" says Dr. Orser. \"The addition of microbial screening to retail marijuana testing has been a positive step by Colorado to come into line with standardization in cannabis testing.\" Colorado has yet to make quality assurance testing of medical marijuana products mandatory, but the state is planning to commence a comprehensive medical marijuana testing program in 2016.\n\n\"Knowing that pesticide-contam...